{"id":53654,"date":"2012-10-06T15:22:42","date_gmt":"2012-10-06T15:22:42","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/transfusion-medicine-rfid-consortium-details-plans-for-commercializing-technology-to-track-and-monitor-blood-products.php"},"modified":"2012-10-06T15:22:42","modified_gmt":"2012-10-06T15:22:42","slug":"transfusion-medicine-rfid-consortium-details-plans-for-commercializing-technology-to-track-and-monitor-blood-products","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/transfusion-medicine-rfid-consortium-details-plans-for-commercializing-technology-to-track-and-monitor-blood-products.php","title":{"rendered":"Transfusion Medicine RFID Consortium details plans for commercializing technology to track and monitor blood products &#8230;"},"content":{"rendered":"<p><p>    PORTLAND, Ore., Oct. 5, 2012 \/PRNewswire\/ --The    Transfusion Medicine RFID Consortium announced today that    S3Edge Inc., the software partner for the consortium has been    selected to exclusively commercialize the RFID and barcode    based Blood Product Tracking suite of applications designed and    built under a private, academic, and public initiative funded    by the NIH. The system, consisting of mobile, desktop, and    server software applications provides greater visibility to the    physical movement of blood products, while improving the    efficiency of Blood Center operations. The RFID    consortium includes BloodCenter of Wisconsin, SysLogic Inc.,    S3Edge Inc., Carter Bloodcare, Mississippi Blood Services, the    University of Iowa Hospitals and Clinics, Mississippi Baptist    Health System, University of Wisconsin Madison  RFID    Laboratory, and Mediware Corp.  <\/p>\n<p>    The suite of applications has been deployed in a production    pilot at the BloodCenter of Wisconsin and the University of    Iowa Hospitals and Clinics (UIHC) with promising results.    \"Thanks to the outstanding work of the entire consortium team,    we have successfully piloted the new system to track blood    products as they move from fixed and mobile donation sites,    through the blood center and to distribution. After 24 weeks of    running the system in a pilot mode here at the BloodCenter of    Wisconsin, we have seen process efficiency and traceability    gains, as well as marked improvements in reconciliation,\" said    Lynne Briggs, Vice President and Chief Information Officer for    BloodCenter of Wisconsin in Milwaukee.  <\/p>\n<p>    The hospital transfusion services tracking module was piloted    at the DeGowin Blood Center at UIHC where it was run in    parallel with IPR, an internally developed barcode-based    tracking system. \"The RFID system provided equivalent    capabilities to those of IPR in terms of detecting and    resolving process errors. It additionally provided the    blood bank staff real-time visibility for blood products in    transit from the hospital blood bank to the point-of-care and    in remote storage in our emergency department.\" said Dr.    Thomas J. Raife, MD, Clinical Professor    & Medical Director, UIHC DeGowin Blood Center.  <\/p>\n<p>    The initiative to introduce RFID technology in transfusion    medicine is also a showcase of how ground-breaking solutions    can be very effectively designed, developed, and commercialized    via private-academic-public initiatives for the healthcare    industry. \"This effort represents the culmination of years of    hard work by the consortium members in bringing a much needed    innovation to the market in a collaborative manner. We are    pleased to see S3Edge taking the next steps to ensure that the    cumulative efforts of the consortium benefit the transfusion    medicine industry as a whole,\" said Rodeina Davis who was    the principal investigator for the STTR grant, and a luminary    in the transfusion medicine field recognized for her role in    advancing this new technology from idea to adoption.  <\/p>\n<p>    SysLogic Inc., one of the founding members of the consortium    and awardee of the STTR grant allowing for creation of the    system will continue to spearhead efforts to obtain the 510(k)    clearance for the blood product tracking suite of applications    developed by the consortium. \"Today's announcement solidifies    our commitment not just to create compelling technology, but to    realize the vision of creating a successful product for the    transfusion medicine industry. We look forward to completing    the requirements for the 510(k) clearance and facilitate the    technology's potential to transform current operations in the    transfusion medicine industry for all end-users,\" said Tina    Chang, CEO of SysLogic Inc., a Brookfield, Wisconsin-based    information systems consulting and services firm.  <\/p>\n<p>    \"S3Edge is extremely pleased to lead the commercialization    effort and make the technology broadly available to the    transfusion medicine industry. This significant milestone could    not have happened without the efforts, guidance and leadership    of the consortium. We look forward to working in tandem with    this team of health care stakeholders and distinguished    researchers to ensure Blood Centers around the world can take    full advantage of this new system,\" said Mark Anastas,    President of S3Edge Inc.  <\/p>\n<p>    To learn more about the RFID blood product tracking initiative    and the commercialization plans, visit the S3Edge booth (#579)    at the AABB Annual Meeting & CTTXPO 2012 to be held in    Boston from October 6-9th, 2012.   <\/p>\n<p>    About S3Edge Inc.  <\/p>\n<p>    S3Edge Inc., a member of the TM RFID Consortium    (<a href=\"http:\/\/www.transfusionmedicinerfid.org\" rel=\"nofollow\">http:\/\/www.transfusionmedicinerfid.org<\/a>)    is a software product company that provides packaged,    Auto-ID-based tracking solutions for automation and error    proofing of healthcare supply chain operations.    Spotlight, S3Edge's software product enables enterprises to    configure and view assets, zones, alerts, and reports and to    track and obtain trends on asset movement within their    organizations. For more information, visit <a href=\"http:\/\/www.s3edge.com\" rel=\"nofollow\">http:\/\/www.s3edge.com<\/a>.  <\/p>\n<p>    Press-Release Contact: Anush Kumar, S3Edge Inc., E-mail:        <a href=\"mailto:anush@s3edge.com\">anush@s3edge.com<\/a>, Phone: 424-832-113.  <\/p>\n<\/p>\n<p>Continue reading here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/transfusion-medicine-rfid-consortium-details-130500766.html;_ylt=A2KJ3CazTHBQ4lkAhjz_wgt.\" title=\"Transfusion Medicine RFID Consortium details plans for commercializing technology to track and monitor blood products ...\">Transfusion Medicine RFID Consortium details plans for commercializing technology to track and monitor blood products ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PORTLAND, Ore., Oct. 5, 2012 \/PRNewswire\/ --The Transfusion Medicine RFID Consortium announced today that S3Edge Inc., the software partner for the consortium has been selected to exclusively commercialize the RFID and barcode based Blood Product Tracking suite of applications designed and built under a private, academic, and public initiative funded by the NIH.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/transfusion-medicine-rfid-consortium-details-plans-for-commercializing-technology-to-track-and-monitor-blood-products.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-53654","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/53654"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=53654"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/53654\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=53654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=53654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=53654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}